Delta Cure - 3nd International Meeting | Milan, October 11-12, 2024
  • Delta Cure - 3nd International Meeting | Milan, October 11-12, 2024

Delta Cure - 3nd International Meeting | Milan, October 11-12, 2024

Dear Colleagues and Friends, It’s a great pleasure to invite...

Dear Colleagues and Friends,

It’s a great pleasure to invite you to the 3rd Edition of Delta Cure International Meeting to be held in Milan, Italy, on October 11-12, 2024.

We are organizing an exciting meeting in a hospitable environment that will certainly favor an important scientific exchange. Infact, The Delta Cure Meeting will review the last evidences in terms of virology, pathogenesis and epidemiology, diagnosis and endpoints.
Two full sessions will be dedicated to thoughtfully debate the most recent advances in terms of current and new antiviral treatments. We will also discuss suggestions for treatment algorithms which will be included in a meeting report to be published in a leading journal of the field. The Faculty will involve an excellent panel of Experts who will guide the attendees through all the challenges of this disease. In particular, we want to encourage young scientists to contribute in topical scientific sessions by submitting abstracts.

Milan is a vibrant cosmopolitan center where the various cultures of northern European and Mediterranean countries merge; it has a lot to offer: art museums, history, opera (La Scala), music, fashion, design, culinary delights and business opportunities. Milan is easy to reach by all means of transport, but is one of the most accessible cities in Europe in terms of air links through 3 international airports (Malpensa, Linate and Orio al Serio).
Furthermore, Milan has the largest public transport network which let people travel around the city urban community and the region easily and quickly.

We hope this event has given you the opportunity to focus on the newest scientific trends in our field in an atmosphere of Italian hospitality and the Italian expression of European Union.
We are sure that - forty-five years after the discovery of HDV - this Meeting has shed new exciting lights on the management of this difficult-to-treat disease.

Thank you for you participation in Milan!

Pietro Lampertico and Heiner Wedemeyer

With the endorsement of

Università degli Studi di Milano
Easl
Elpa
EpaC
EpaC
×

Icon